Mark L Pacala is Director of Oncology Institute, Inc.. Currently has a direct ownership of 134,409 shares of TOI, which is worth approximately $43,010. The most recent transaction as insider was on Nov 22, 2024, when has been sold 50,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 134K
0.46% 3M change
0.46% 12M change
Total Value Held $43,010

Mark L Pacala Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 22 2024
BUY
Grant, award, or other acquisition
-
50,000 Added 27.11%
134,409 Common Stock
Nov 12 2024
SELL
Other acquisition or disposition
-
50,620 Reduced 37.49%
84,409 Common Stock
Dec 26 2023
BUY
Grant, award, or other acquisition
-
46,630 Added 25.67%
135,029 Common Stock
Mar 17 2023
BUY
Grant, award, or other acquisition
-
6,562 Added 6.91%
88,399 Common Stock
Nov 17 2022
BUY
Grant, award, or other acquisition
-
31,217 Added 27.61%
81,837 Common Stock
MLP

Mark L Pacala

Director
Cerritos, CA

Track Institutional and Insider Activities on TOI

Follow Oncology Institute, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TOI shares.

Notify only if

Insider Trading

Get notified when an Oncology Institute, Inc. insider buys or sells TOI shares.

Notify only if

News

Receive news related to Oncology Institute, Inc.

Track Activities on TOI